MSHLRituximab (Truxima) Concentrate For Infusion 100 mg/10 mL, 500 mg/50 mL
1) Ibrutinib in combination with rituximab for previously untreated chronic lymphocytic leukaemia (CLL) or small lymphocytic lymphoma (SLL).
2) Ibrutinib in combination with rituximab, for the treatment of Waldenstrom’s Macroglobulinaemia.